← Back to Epithalon product page
Induction of Telomerase Activity and Telomere Elongation in Human Somatic Cells
A foundational 2003 study published in the Bulletin of Experimental Biology and Medicine investigated whether the Epithalon peptide could induce telomerase activity and telomere elongation in human somatic cells. The researchers added Epithalon to cultures of human fetal fibroblasts and pulmonary epithelial cells and measured telomerase activity, telomerase gene component expression, and telomere length changes compared to untreated control cultures.
The results demonstrated that Epithalon addition to cell culture media induced expression of the catalytic subunit of telomerase (hTERT), activated telomerase enzyme activity, and produced telomere elongation averaging 33.3% in treated cells. The reactivation of telomerase in somatic cells — which normally lack telomerase expression — was a significant finding, as telomere shortening is a well-characterized marker of cellular aging and replicative senescence. The authors noted that these findings indicate the possibility of extending the replicative lifespan of somatic cells through peptide-mediated telomerase reactivation.
Citation: Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon Peptide Induces Telomerase Activity and Telomere Elongation in Human Somatic Cells. Bulletin of Experimental Biology and Medicine. 2003;135(6):590-592. doi:10.1023/a:1025493705728. PubMed PMID: 12937682
Telomere Length Modulation Through Telomerase Upregulation and ALT Activity
A 2025 study published in GeroScience further characterized the mechanisms by which Epithalon increases telomere length in human cell lines. The researchers evaluated Epithalon’s effects across multiple cell types, including telomerase-positive and telomerase-negative (ALT-dependent) cell lines, to determine whether the peptide acts exclusively through telomerase upregulation or also engages alternative lengthening of telomeres (ALT) pathways.
The investigation confirmed that Epithalon increases telomere length in human cell lines and identified two distinct mechanisms: telomerase upregulation in telomerase-competent cells and activation of ALT (alternative lengthening of telomeres) activity in telomerase-negative cells. This dual-mechanism finding was novel and suggested that Epithalon’s effects on telomere biology are broader than previously appreciated, engaging multiple telomere maintenance pathways rather than acting solely through hTERT expression.
Citation: Borg L, Brincat S, Calleja-Agius J, et al. Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. GeroScience. 2025;47(3):3405-3422. doi:10.1007/s11357-025-01578-0. PMC: PMC12411320
Overview of Bioactive Properties: Pineal Gland, Retina, and Brain
A comprehensive 2025 review published in Molecules evaluated the bioactive properties of Epithalon across multiple organ systems. The review compiled evidence from decades of preclinical research, focusing on the peptide’s effects on pineal gland function, retinal biology, and central nervous system processes.
The review documented that Epithalon regulates the function of the pineal gland, with documented effects on melatonin synthesis and circadian gene expression. In the retina, Epithalon demonstrated protective effects in animal models of retinal degeneration. The review also reported that in animal studies, Epithalon increased longevity and decreased experimental carcinogenesis in multiple rodent models. The authors noted that Epithalon’s effects on melatonin synthesis through pineal gland regulation may contribute to its broader biological effects, as melatonin itself possesses well-documented antioxidant, immunomodulatory, and chronobiological properties.
Citation: Kocsis T, Racz B, Szabo D, et al. Overview of Epitalon — Highly Bioactive Pineal Tetrapeptide with Promising Properties. Molecules. 2025;30(6):1218. doi:10.3390/molecules30061218. PMC: PMC11943447
Pineal Peptide Regulation of Melatonin and BDNF Expression
Research has established that Epithalon’s effects extend to the regulation of brain-derived neurotrophic factor (BDNF) and cyclic-AMP responsive element binding protein 1 (CREB1) through its modulation of melatonin synthesis and circadian gene expression. In preclinical models, Epithalon administration was associated with normalization of melatonin production in aged animals, restoring nocturnal melatonin peaks toward levels characteristic of younger animals.
The connection between Epithalon, melatonin synthesis, and BDNF expression is mechanistically significant. Melatonin is known to upregulate BDNF expression through CREB-dependent signaling pathways. By restoring melatonin production in aged animals, Epithalon may indirectly support neurotrophic factor expression and the downstream processes of synaptic plasticity and neuronal survival that BDNF mediates. This proposed cascade — from pineal peptide to melatonin to BDNF — represents an indirect neuromodulatory mechanism distinct from direct neuroprotective peptides like Semax or Selank.
Citation: Khavinson V, Linkova N, Dyatlova A, et al. Peptides: Prospects for Use in the Treatment of COVID-19. Molecules. 2020;25(19):4389. doi:10.3390/molecules25194389. PubMed PMID: 32987704
Longevity Effects in Animal Models
Multiple preclinical studies conducted by Khavinson and colleagues have evaluated Epithalon’s effects on lifespan in rodent models. In studies using aging rats and mice, chronic Epithalon administration was associated with increased mean and maximum lifespan compared to control animals. The proposed mechanisms for these longevity effects include telomerase reactivation in somatic tissues, restoration of pineal gland melatonin production, modulation of antioxidant enzyme expression, and suppression of age-related tumor development.
In one series of experiments, Epithalon administration to aging rats was associated with reduced incidence of spontaneous tumor formation and increased survival times. The anti-tumor effects were proposed to result from improved immunosurveillance mediated by restored melatonin-dependent circadian regulation of immune function. While these results are compelling, they derive primarily from a single research group and await independent replication to establish the robustness of the longevity findings across different laboratory settings and animal strains.
Citation: Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon Peptide Induces Telomerase Activity and Telomere Elongation in Human Somatic Cells. Bulletin of Experimental Biology and Medicine. 2003;135(6):590-592. doi:10.1023/a:1025493705728. PubMed PMID: 12937682
Reviewed for scientific accuracy — Chameleon Peptides Research Team. Last reviewed: March 2026.